The murine blast cell colony assay offers a unique method to study the mechanisms controlling the primitive hemopoietic progenitors (1). The progenitors for the blast cell colonies present in mice treated with 5-fluorouracil (5-FU)' probably represent the most primitive stem cells difinable in culture (2). Current studies have shown that IL-3 and granulocyte-macrophage CSF (GM-CSF) have direct action on the development of multipotential hemopoietic progenitors as well as committed progenitors (3, 4). Hemopoietin-1 (5, 6), which is probably identical to IL-1a (7), and a growth factor(s) produced by a murine adherent marrow cell line (8) have been reported as a new class ofhemopoietic growth factors with synergistic activities on multilineage colony formation. These factors have been demonstrated to possess no capacity to stimulate hemopoietic colony formation by themselves but enhance the effects of other hemopoietic factors.
The murine blast cell colony assay offers a unique method to study the mechanisms controlling the primitive hemopoietic progenitors (1) . The progenitors for the blast cell colonies present in mice treated with 5-fluorouracil (5-FU)' probably represent the most primitive stem cells difinable in culture (2) . Current studies have shown that IL-3 and granulocyte-macrophage CSF (GM-CSF) have direct action on the development of multipotential hemopoietic progenitors as well as committed progenitors (3, 4) . Hemopoietin-1 (5, 6) , which is probably identical to IL-1a (7) , and a growth factor(s) produced by a murine adherent marrow cell line (8) have been reported as a new class ofhemopoietic growth factors with synergistic activities on multilineage colony formation. These factors have been demonstrated to possess no capacity to stimulate hemopoietic colony formation by themselves but enhance the effects of other hemopoietic factors.
Human B cell stimulatory factor 2/interleukin 6 (BSF 2/IL-6) (9), identical to IFNa-2 (10, 11), a 26-kD protein (12) hybridoma/plasmacytoma growth factor (13) , has been demonstrated to act on the proliferation and differentiation of B cells at the late stage and induce the production of Ig. Recently, Ikebuchi et al. (14) presented evidence that human BSF2 interacts with IL-3 on murine multipotential progenitors, and at least part of the effect results from a decrease in the Go period of the individual stem cells.
In this study, we examined the effects of human BSF2 on the development of murine hemopoietic progenitors using serum-free and serum-containing culture systems.
Results
Dose Response of Colony Formation to BSF-2. To determine the optimal concentration of BSF 2, we examined colony formation by 2 x 106 spleen cells of 5-FU-treated mice at BSF2 concentrations from 0.6-160 ng/ml in the presence of FCS. The maximal number oftotal colonies was seen with 40-160 ng/ml of BSF2 as shown in Fig.  1 . Thus, BSF2 at 80 ng/ml was used in subsequent studies.
Colony Formation Supported by BSF-2 or IL-3 in Serum-containing Culture. We compared the types and numbers ofcolonies formed in serum-containing culture by spleen cells of normal and 5-FU-treated mice supported by 80 ng/ml of BSF2 with those supported by 400 U/ml of IL-3, which was shown to be the optimal concentration for the development of various types of colonies (3, 18, 22) . The results are presented in Table I . The number of total colonies supported by BSF2 was approximately one-fifth and one-half ofthose supported by IL-3 derived from spleen cells of normal mice and 5-FU-treated mice, respectively. Many different types of colonies including GM, M, GMM, MAST, and blast cell colonies were formed in the presence ofIL-3 . Serial observations of culture dishes containing spleen cells of normal or 5-FU-treated mice demonstrated that BSF2 supported sequential appearance of blast cell colonies after day 7, similar to those supported by IL-3 or GM-CSF (4, 22) . Most of the blast cell colonies showed terminal differentiation into GM, M, and GMM colonies until 16 d of incubation . However, some of them retained the morphological characteristics of blast cell colonies on day 16. BSF2 did not support mast cell colony formation. Cytological analysis showed that the 11 randomly chosen mature day 16 colonies supported by BSF2 derived from spleen cells of normal mice consisted of one macrophage colony, two megakaryocyte colonies, four neutrophil-macrophage colonies, and four neutrophil-macrophage-megakaryocyte colonies .
Replating Experiment ofBlast Cell Colonies Supported by BSF-2. Since most ofthe colonies supported by BSF2 revealed an early nature, we examined the potentiality of blast cell colonies grown in the presence of BSF2 derived from spleen cells of normal mice and 5-FU-treated mice using replating experiments. Spleen cells (4 x 105) of normal mice were plated in a culture dish containing 80 ng/ml of BSF2 and FCS. 17 colonies were seen in a culture dish until day 16. Seven of them were identified as small GM colonies on day 7. We individually lifted and replated 8 out of 10 blast cell colonies seen from day 7-15 into secondary culture dishes containing 2 U/ml of Ep and 10°Jo PWM-SCM. The results are presented in Table II . Blast cell colonies revealed variable but high replating efficiencies . Five out of eight blast cell colonies yielded secondary multilineage colonies including GEM, GMM, and GEMM colonies . These results were comparable with those obtained by the replating experiment of blast cell colonies derived from spleen cells of 5-FU-treated mice in the presence of 80 ng/ml of BSF2. These results suggested that BSF2 supported the proliferation of multipotential progenitors preferentially in the presence of serum.
Colony Formation Supported by BSF-2 or II,-3 in Serum,free Culture. Since FCS is potentially an endogenous source of various types of colony stimulating factors, we carried out studies using the serum-free culture technique (18) . The number of total colonies formed by spleen cells of 5-FU-treated mice grown in the presence of 10% PWM-SCM in serum-free culture conditions was -80% of that formed in serumcontaining culture conditions (data not shown) . Table III Number of colonies was derived from a total of 2 .4 x 106 spleen cells of normal mice and from a total of 4 x 10 6 spleen cells of 5-FU-treated mice in four dishes . BSF-2, 80 ng/ml ; IL-3, 400 U/ml .
colony formation supported by BSF2 and IL-3 in serum-free culture. IL-3 supported the development of many different types of colonies by spleen cells of both normal mice and 5-FU-treated mice . In contrast, no colony growth was seen in the presence of BSF2 . These results suggest that BSF2 does not support colony formation by itself and requires factor(s) present in the serum for colony formation. Effect of Combination ofBSF-2 and IL-3 in Serumfree Culture. Since IL-3 is one of the most important factor(s) on the proliferation and differentiation ofthe hemopoietic progenitors (23, 24) , it is possible that IL-3 is a candidate cooperating with BSF2 in the serum. We examined the effects ofBSF2 on the development ofvarious types of progenitors supported by an optimal concentration of IL-3 . First, spleen cells of normal mice were plated in culture dishes containing 2 U/ml of Ep, 400 U/ml of IL-3, and/or 80 ng/ml of BSF2 . As shown in Table IV , BSF2 did not increase the number of total colonies or that of erythroid bursts supported by Ep. These results suggested that BSF2 does not have a burst-promoting activity. BSF2 did not augment the single lineage colony growth (B, M, mast cell colony) or oligolineage colony growth (GM, EM colony) supported by 400 U/ml of IL-3 and Ep, which suggests that BSF2 does not influence the development of maturer progenitors. The sum ofthe numbers of GEM, GMM, GEMM, and blast cell colonies produced by spleen cells cultured with Ep, IL-3, and BSF2 was similar to that produced by culture with Ep and IL-3 . However, the majority ofmultipotential progenitors supported by BSF2, IL-3, and Ep developed into GEMM colonies on day 16. On the other hand, in IL-3-and Ep-containing culture, halfof them remained in the developmental stages of GMM and blast cell colonies on day 16 and mostly differentiated into GEMM colonies after day 16.
To study the precise effect ofBSF2 on the development of multipotential progen- Number of colonies was derived from a total of 1 .6 x 106 spleen cells of normal mice in four dishes . BSF-2, 80 ng/ml ; IL-3, 400 U/ml ; Ep, 2 U/ml .
itors, we used spleen cells of 5-FU-treated mice in which primitive cells were enriched . The results are presented in Table V . The addition of BSF 2 to the culture containing 400 U/ml of IL-3 resulted in a significant increase in the number of total colonies, including many GMM colonies. Since BSF-2 was prepared by expressing a cDNA for BSF2 in E. coli, it is possible that the effects of BSF2 resulted from endotoxin present in BSF2 samples . Therefore, we examined whether the action of BSF2 was abolished by polymyxin B. Addition of polymyxin B (10 pg/ml) did not remove synergism of BSF2 and IL-3 (data not shown).
Effect of BSF-2 on Colony Formation Supported by suboptimal Concentrations of IL-3 in Serumflee Culture. Next, we examined the mechanism of synergism between BSF2 and IL-3 . We plated spleen cells of 5-FU-treated mice in the presence of 80 ng/ml of BSF2 and/or 1 or 4 U/ml of IL-3 . The results are presented in Table VI . As shown in the previous sections, no colony growth was seen in culture with BSF2 alone. Very low concentrations of IL-3 supported the growth of zero or two colonies . On the other hand, a combination of BSF2 and IL-3 resulted in a significant increase in the number of colonies . Similar results were obtained in the culture containing bone marrow cells of 5-FU-treated mice . The combination of 80 ng/ml of BSF2 and 4 U/ml of IL-3 supported the formation of seven colonies (six M, one GMM) from 1.2 x 10 5 cells in three dishes, while each factor alone failed to support the colony growth . It is possible that new colonies are formed in the culture with IL-3 alone and not with the combination of BSF2 and IL-3 after day 16 of incubation, since Ikebuchi et al . (14) reported that human BSF2 shortens the time course of appearance of colonies . Therefore, cultures containing spleen cells of 5-FU-treated mice were maintained until day 30, and sequential observations were carried out. A significant number of new colonies was seen in the presence of BSF2 and IL-3 after day 16 of incubation ; whereas, few new colonies grew with IL-3 alone (Table VI) . We previously demonstrated that the multilineage colonies appeared smaller in lower concentrations of IL-3 than in higher concentrations of IL-3 (22) . Based on these results, we examined whether BSF2 was capable of enlarging the GMM colonies supported by 40 U/ml of IL-3 derived from spleen cells of 5-FU-treated mice . When a colony appeared to have matured and did not change its morphology or size for 3 d, it was lifted from the methylcellulose medium by use of an Eppendorf micropipet for the determination of colony size and morphological examination. The results in Fig. 2 show a significant difference in the size of GMM colonies between the BSF2 and IL-3 group and the IL-3 group (p < 0.001) according to Student's t test on logarithms of the cell numbers of individual colonies, although BSF2 alone failed to support the colony growth . By contrast, there was no difference in the size of the mast cell colonies between the two groups . These results suggested that BSF2 enhanced the sensitivity of multipotential hemopoietic progenitors to a low concentration of IL-3 .
Effect ofAnti-IL-la Serum on Colony Formation Supported by BSF-2 and IL-3. Since Hemopoietin-1, probably identical to IL-1a (7), has been demonstrated to possess Numbers of colonies derived from a total of 3 x 10 6 (Exp . 1) and 3 .6 x 106 (Exp . 2) spleen cells of 5-FU-treated mice in three dishes were counted until day 16 and numbers of colonies in parentheses until day 30 .
Colony type
Exp . 1
2) IL-3(4 U/ml) + BSF-2(80 ng/ml) 3(6) 6 (7) 12 (22) 0(0) 1(0) 22 (35) synergism with IL-3 (6), we examined whether the antiserum against human IL-la absorbed the synergistic effect of BSF2 using serum-free culture system . We therefore added the anti-IL-1a serum to the culture dishes containing spleen cells of 5-FU-treated mice with 40 U/ml of IL-3 and 80 ng/ml of BSF2 or 2 ng/ml of IL1a . The results are presented in Fig. 3 . IL-la did not support colony formation by itself but increased the number of total colonies grown in the presence of IL-3 . The effect of 2 ng/ml of IL-la on the IL-3-dependent colony growth, comparable with that of 20 ng/ml of IL-1a (data not shown), was less effective than that of BSF2 as reported by Ikebuchi et al . (14) . A 1:2,000 dilution of anti-IL-la serum reduced the colony growth supported by IL-3 and IL-la to the level seen in culture with IL-3 alone. On the other hand, the synergistic action between BSF2 and IL-3 was not precipitated by the addition of antiserum.
Discussion
As previously indicated, IL-3 has been shown to support proliferation and differentiation of multipotential progenitors as well as committed progenitors to single lineages (3). Murine GM-CSF also has been demonstrated to possess direct effects on not only GM progenitors but also multipotential progenitors, and the primitive cells responding to GM-CSF are subpopulations of multipotential progenitors supported FIGURE 3. Effect of anti-IL-la serum on colony formation supported by IL-3 andBSF2 or ILla . The number of colonies derived from a total of 2.4 x 10 6 spleen cells of 5-FU-treated mice was counted. IL-3, 40 U/ml ; BSF2, 80 ng/ml; IL-1 a, 2 ng/ml; Anti-IL-la serum, 1:2,000 . by IL-3 (4). On the other hand, hemopoietin-1 produced no hemopoietic colonies by itself in the presence of FBS but acted synergistically with CSF1 in the generation of mononuclear phagocytic precursor cells (5) and with IL-3 on development of multipotential hemopoietic cells (6). Quesenberry et al . (8) reported a growth factor(s) in the medium conditioned by murine marrow-adherent cell line, TC-1, which has shown multilineage synergistic activities with IL-3, GM-CSF, and CSF1 on bone marrow cells of normal and 5-FU-treated mice using a serum-containing culture condition. They showed that this factor differs from hemopoietin-1, and the major synergistic effect is on the size rather than on the number of colonies . The present study demonstrated that BSF2 supports multipotential blast cell colony formation by spleen cells of normal and 5-FU-treated mice in the presence of serum . These results were consistent with those reported by Ikebuchi et al . (14) . However, use of a serum-free culture method showed BSF2 alone has no effect on colony growth, suggesting that BSF2 fails to support colony formation by itself. Combination of BSF2 and IL-3 in serum-free culture resulted in a significant increase of colony formation by spleen cells and bone marrow cells of 5-FU-treated mice in comparison with IL-3 alone; whereas, no effect by the addition of BSF2 was seen on the number of single or oligolineage colonies by spleen cells of normal mice supported by IL-3 and/or Ep. These results suggested that BSF2 and IL-3 act synergistically on the multipotential progenitors and not on that of the maturer progenitors. Addition of BSF2 to culture with a low concentration of IL-3 with little effect on colony formation resulted in a significant increase in the number of colonies . Synergistic activities of BSF2 and a low concentration of IL-3 was also seen on the size of GMM colonies . These results suggested that BSF2 enhances the susceptibility of multipotential progenitors to IL-3 .
Hemopoietin-1, probably identical to IL-1a (7), was reported to act synergistically with IL-3 on development of multipotential hemopoietic cells (6) . Our serumfree culture study demonstrated that IL-1a also failed to support colony formation by itself but enhanced the IL-3-dependent colony growth . However, synergistic action of BSF2 was more effective than that of IL-1a and was not absorbed by the addition of anti-IL-1a serum, suggesting that potentiating activity of BSF-2 was distinguishable from that of IL-la.
BSF2 supported multipotential blast cell colony formation and differentiation of hemopoietic progenitors into neutrophil, macrophage, and megakaryocyte lineage in the presence of serum. Serum-free culture demonstrated that BSF2 requires factor(s) present in serum for the manifestation of the activities . Combination of BSF2 and IL-3 suggested that IL-3 is a candidate for synergistic action with BSF2 . The level of IL-3 in our FBS was <1 U/ml, according to the measurement using an IL-3-dependent cell line, 32 D-cl line (data not shown) . Addition of 1 U/ml of IL-3 to serum-free culture containing BSF2 failed to restore the number of total colonies to the level obtained by serum-containing culture with BSF2 alone, when spleen cells of 5-FU-treated mice were used (data not shown) . Therefore, some factors other than IL-3 in FBS may also act with BSF2 synergistically. It may be related to the results that BSF2 supported formation of small GM colonies until day 7 from spleen cells of normal mice in a serum-containing culture condition.
BSF2 may possess several functions on hemopoietis. One of them is that BSF2 may advance the maturation of multipotential progenitors, because BSF2 hastened the differentiation ofmultipotential progenitors in the culture with IL-3 and Ep when target cells were spleen cells of normal mice. It appears to be related to the evidence described by Ikebuchi et al. (14) , that the combination of BSF 2 and IL-3 hastened the rate ofcolony appearance relative to that observed with either factor alone. However, augmentation ofBSF2 on number and size ofcolonies supported by low IL-3 cannot be interpreted by this mechanism . Another mechanism of synergism will be proposed that BSF2 enhances the sensitivity of multipotential progenitors to IL-3 . If the activities of IL-3 on hemopoietic progenitors are mediated by receptors, it may suggest that BSF2 increases the numbers of receptors to IL-3 or upregulates the affinity of receptors to IL-3 on the multipotential progenitors . Further studies are required .
Summary
We investigated the effects of B cell stimulatory factor 2/interleukin 6 (BSF-2/IL-6) on the development of murine hemopoietic progenitors using serum-containing culture and serum-free culture . In serum-containing culture, BSF2 mainly supported multipotential blast cell colonies from spleen cells of normal and 5-fluorouracil (5-FU)-treated mice. In serum-free culture, no colony growth was seen in the presence of BSF-2 . Addition of BSF-2 to the serum-free culture containing IL-3 resulted in a significant increase in the number of colonies formed from multipotential progenitors in spleen cells and bone marrow cells of 5-FU-treated mice, whereas no effects were seen on the number of single or oligolineage colonies formed by the spleen cells of normal mice. These results suggested that BSF2 and IL-3 act synergistically on the multipotential progenitors but not on the maturer progenitors . When BSF2 was added to a culture containing low concentrations of IL-3 (1 U/ml, 4 U/ml), which had little effect on colony formation, the number of total colonies formed by the spleen cells and bone marrow cells of 5-FU-treated mice increased significantly. The combination of BSF2 and 40 U/ml of IL-3 resulted in a significant enlargement ofGMM colonies. Thus, BSF-2 appears to enhance the sensitivity of multipotential hemopoietic progenitors to IL-3 .
